China SXT Pharmaceuticals, Inc.
SXTC
$3.90
$0.6018.20%
NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
--
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.00% | -18.38% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.00% | -18.38% | |||
| Cost of Revenue | 0.00% | -30.53% | |||
| Gross Profit | 0.00% | 44.40% | |||
| SG&A Expenses | 0.00% | -85.54% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.00% | -81.40% | |||
| Operating Income | 0.00% | 87.63% | |||
| Income Before Tax | 0.00% | 102.57% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 0.00% | 102.57% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.00% | 102.57% | |||
| EBIT | 0.00% | 87.63% | |||
| EBITDA | 0.00% | 88.23% | |||
| EPS Basic | -- | -- | |||
| Normalized Basic EPS | -- | -- | |||
| EPS Diluted | -- | -- | |||
| Normalized Diluted EPS | -- | -- | |||
| Average Basic Shares Outstanding | -- | -- | |||
| Average Diluted Shares Outstanding | -- | -- | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||